Onesource Specialty Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26
Onesource Specialty Pharma Ltd · Outcome · 27 Oct 2026, 3:36 pm
Onesource Specialty Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 5,162 (+37.4% YoY | +15.0% QoQ) ■ EBITDA: 1,633 (+53.3% YoY | +32.4% QoQ) ■ EBITDA Margin (%): 31.6 (+329 bps YoY | +416 bps QoQ) ■ PAT: 575 (+448.2% YoY | +130.0% QoQ) ■ EPS (INR): 5.01 (+450.5% YoY | +129.8% QoQ)
Original exchange filing (PDF)
More announcements from Onesource Specialty Pharma Ltd
- Intimation of resignation of Senior Management Personnel · 17 Nov 2026
- Onesource Specialty Pharma Limited has informed the Exchange about the Participation in Jefferies Global Healthcare Conference to be held from November 16, 2026 to November 19, 2026 in London. · 05 Nov 2026
- Intimation of Transcript of Earnings call dated October 27, 2026 · 03 Nov 2026
- OneSource receives USFDA EIR with VAI Classification, Marking completion of Inspection process at its Sterile Product Division (SPD) Facility in Bengaluru. · 30 Oct 2026
- Intimation of the Audio recording of the earnings call pertaining to the unaudited financial results for the quarter and half year ended September 30, 2026 · 28 Oct 2026
- OneSource announces strong Q2FY27, results revenue up 37% YoY and EBITDA up 53% YoY · 27 Oct 2026
- Intimation of allotment of 360 equity shares of Re.1/- each under ONESOURCE ESOP 2021 on October 27, 2026. · 27 Oct 2026
- Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company. · 27 Oct 2026
